This study tested a single-shot vaccine designed to protect against two common respiratory viruses: RSV and human metapneumovirus (hMPV). It involved 264 healthy adults aged 60 to 85. The main goals were to check the vaccine's safety and see how well it triggered an immune respon…
Phase: PHASE2 • Sponsor: Icosavax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:41 UTC